Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Avrobio Inc (NQ: AVRO ) 1.400 UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Avrobio Inc < Previous 1 2 3 4 5 6 7 Next > AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 08, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO to Participate in Four Upcoming Investor Conferences in September August 31, 2022 From AVROBIO, Inc. Via Business Wire Recap: Avrobio Q2 Earnings August 09, 2022 Avrobio (NASDAQ:AVRO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update August 09, 2022 From AVROBIO, Inc. Via Business Wire Avrobio's Pompe Disease Gene Therapy Shows Efficacy, Safety In Preclinical Study May 18, 2022 Via Benzinga AVROBIO Shares Jumps On Encouraging Data From Early-Stage Gene Therapy Study May 17, 2022 Via Benzinga Avrobio: Q1 Earnings Insights May 10, 2022 Avrobio (NASDAQ:AVRO) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 04, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO to Participate in Two Upcoming Investor Conferences in August August 01, 2022 From AVROBIO, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session July 29, 2022 Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 13, 2022 Via Benzinga Recap: Avrobio Q4 Earnings March 17, 2022 Avrobio (NASDAQ:AVRO) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga AVROBIO Shares Climb As FDA Grants Orphan Drug Status To Genetic Disorder Candidate July 13, 2022 The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVROBIO’s (NASDAQ: AVRO) lead drug AVR-RD-05 for the treatment of mucopolysaccharidosis type II (MPSII), or Hunter... Via Benzinga AVROBIO Receives Orphan Drug Designation from the U.S. Food and Drug Administration for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome July 13, 2022 From AVROBIO, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 07, 2022 Via Benzinga AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 06, 2022 From AVROBIO Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session June 30, 2022 Gainers Via Benzinga AVROBIO Announces Preclinical Gene Therapy Data for Pompe Disease at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting May 18, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO Reports Positive Data From Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis, Including New Interim Data on Neurocognitive Measures May 17, 2022 From AVROBIO, Inc. Via Business Wire The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More May 16, 2022 Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from... Via Benzinga AVROBIO to Present at the H.C. Wainwright Global Investment Conference May 16, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO Reports First Quarter 2022 Financial Results and Provides Business Update May 10, 2022 From AVROBIO Via Business Wire AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 06, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO to Present New Clinical and Preclinical Data at the ASGCT 25th Annual Meeting May 03, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 06, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO to Present at the 21st Annual Needham Virtual Healthcare Conference April 05, 2022 From AVROBIO, Inc. Via Business Wire AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update March 17, 2022 From AVROBIO, Inc. Via Business Wire After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data February 09, 2022 Avrobio Inc's (NASDAQ: AVRO) gene therapy for a rare lysosomal storage disorder Via Benzinga The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In February 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Stocks That Hit 52-Week Lows On Thursday February 10, 2022 On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN).... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
